# Long-acting Naltrexone for Pre-release Prisoners

> **NCT02867124** · PHASE3 · COMPLETED · sponsor: **Friends Research Institute, Inc.** · enrollment: 240 (estimated)

## Conditions studied

- Opiate Addiction

## Interventions

- **DRUG:** XR-NTX
- **OTHER:** place of residence
- **OTHER:** opioid treatment program

## Key facts

- **NCT ID:** NCT02867124
- **Lead sponsor:** Friends Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2025-02-10
- **Final completion:** 2026-01-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867124, "Long-acting Naltrexone for Pre-release Prisoners". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02867124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*